Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma.
Saved in:
| Title: | Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma. |
|---|---|
| Authors: | Walter C; Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Burger MC; Dr. Senckenberg Institute of Neurooncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany.; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt/Main, Germany., Siebenbrodt K; Department of Neurology, Goethe University Frankfurt, University Hospital, Epilepsy Center Frankfurt Rhine-Main, Frankfurt/Main, Germany., Mooshage CM; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., You SJ; Institute of Neuroradiology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Hattingen E; Institute of Neuroradiology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Scholten F; Department of Internal Medicine 3, Hematology, Oncology, Palliative Medicine and Pneumology, Frankfurt Höchst Hospital, Frankfurt/Main, Germany., Weidner N; Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Wagner B; Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Lang F; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Ajib S; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Oellerich T; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt/Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Bug G; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt/Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany., Hug A; Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Vischedyk JB; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt/Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jul; Vol. 67 (8), pp. 1806-1810. Date of Electronic Publication: 2026 Mar 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2026.2647957 |
